Building a New CDx Ecosystem to Support Early Clinical Development Through Commercial Launch
Time: 5:00 pm
day: Day 1 PM
Details:
- Tempus combines RWD offering with CDx development to optimize biomarker design
- Supporting trial enrollment using design controlled IUO tests
- Improve speed to market using Tempus FDA-approved xT CDx assay
- Immediate commercial access to 1000s of oncologists in the US and growing internationally
